LobbyingIroquois Healthcare Alliance lobbying by quarter
Iroquois Healthcare Alliance's latest lobbying report covers Q2 2026, at $35K. The four quarters Q4 2025–Q3 2026 total $155K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
Iroquois Healthcare Alliance
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $155K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $100K | 1 |
| Q1 2023 | $75K | 1 |
| Q2 2023 | $75K | 1 |
| Q3 2023 | $75K | 1 |
| Q4 2023 | $75K | 1 |
| Q1 2024 | $75K | 1 |
| Q2 2024 | $75K | 1 |
| Q3 2024 | $75K | 1 |
| Q4 2024 | $75K | 1 |
| Q1 2025 | $40K | 1 |
| Q2 2025 | $40K | 1 |
| Q3 2025 | $60K | 1 |
| Q4 2025 | $60K | 1 |
| Q1 2026 | $60K | 1 |
| Q2 2026 | $35K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$887.5K · 15 reports
- Medicare and Medicaid$107.5K · 4 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES15 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseIroquois Healthcare Alliance | $995K | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| KEVIN KERWIN | President and CEO | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/17for Q2 | In-house | $35K |
| 04/17for Q1 | In-house | $60K |
| 01/15for Q4 2025 | In-house | $60K |
| 25/10/20for Q3 2025 | In-house | $60K |
| 25/07/17for Q2 2025 | In-house | $40K |
| 25/04/07for Q1 2025 | In-house | $40K |
| 25/03/10for Q3 2024 | In-house | $75K |
| 25/01/17for Q4 2024 | In-house | $75K |
| 24/10/16for Q3 2024 | In-house | $75K |
| 24/07/11for Q2 2024 | In-house | $75K |
| 24/04/16for Q1 2024 | In-house | $75K |
| 24/01/19for Q4 2023 | In-house | $75K |
| 23/10/12for Q3 2023 | In-house | $75K |
| 23/07/18for Q2 2023 | In-house | $75K |
| 23/04/20for Q1 2023 | In-house | $75K |
| 23/01/18for Q4 2022 | In-house | $100K |